LuckCong's Health Blog

Chinese people and easy to get hepatitis B-related gene? Experts said that this is yet to be demonstrated China is the largest liver cancer It is reported that the number of liver cancer in China accounted for more than half of the world, is worthy of the name of the "largest liver cancer." There are 120,000,000 of the hepatitis B virus carriers, that is to say, every 10 Chinese people were one people were infected with hepatitis B virus. Many people can not help but wonder why the Chinese so easy to get hepatitis B? Is it genetic problem? In response, many experts said could not understand. The University of Hong Kong Professor Liao Jiajie said that the Chinese people are particularly sensitive to the hepatitis B virus may be related to gene-related, but have yet to be confirmed. Long-term use of antiviral drugs to be Recently, newspapers, television ads overwhelming the treatment of hepatitis B: Hepatitis B can be said that some of the ads "completely cured", while others said "Zhibu Hao B," patients need medication for life. These ads many patients with hepatitis B at a loss. In response, Chinese Academy of Sciences et al authority in the field of liver cancer, said the treatment of hepatitis B are currently two types of drugs such as interferon First, the regulation of the immune drugs, but drugs are not suitable for everyone. The other is the anti-viral drugs, these drugs is a ills can not be stopped, the patient must be long-term medication. "Fudan standard" for the benefit of more patients At present, liver transplant in the adaptation of people to choose, is internationally recognized as Italy's Mi-lan standard, the United States standards, such as UCSF. These groups meet the criteria in the selection of relatively harsh. During the meeting, the subsidiary of Fudan University Institute of liver cancer a new standard. Al Academy of Sciences named "Fudan standards" It is understood that the "Fudan standard," an increase of about 25% of the population to adapt to a liver transplant in patients with the survival rate of Milan, UCSF compared to the same amount of money. Zhongshan Hospital last year, 4000 cases of liver transplant patients 1 year survival rate of 88%. Liver drug should not take long The new release of "chronic hepatitis B prevention and treatment guidelines" that the liver over many years a variety of oral drug is not desirable, because there is no good for the liver harmful drug Almighty, in the liver is not completely quiescent best medicine. In addition, the first to take a drug that may well, but the long-term medication, the drug will gradually lose their effect.